🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to evaluate the safety, tolerability, and efficacy o...
Status
Completed
Location
Coastal Clinical Research Inc.
Start Date
2018-06-14
Trial ID
NCT03583372
Treatments Being Tested
This study is designed to evaluate the safety, tolerability, and efficacy o...
Status
Completed
Location
Central Alabama Research
Start Date
2018-03-26
Trial ID
NCT03492281
Treatments Being Tested
Patients with overactive bladder are often treated with tolterodine, a medi...
Status
Completed
Location
Radiant Research, Inc.
Start Date
2011-05
Trial ID
NCT01302054
Treatments Being Tested
The study is intended to test the safety, tolerability, efficacy of two dos...
Status
Completed
Location
Multiple Locations
Start Date
2008-04-25
Trial ID
NCT00688688
Treatments Being Tested
The TRIUMPH study is a randomized, double-blinded, 3-arm, parallel-group tr...
Status
Recruiting
Location
Stanford University
Start Date
2022-10-04
Trial ID
NCT05362292
Treatments Being Tested
The study is designed to investigate the effects of the investigational dru...
Status
Terminated
Location
Multiple Locations
Start Date
2012-02-27
Trial ID
NCT01500382
Treatments Being Tested
The purpose of this study was to assess tolerability of mirabegron compared...
Status
Completed
Location
Site US10002 Urology Centers of Alabama
Start Date
2014-07-24
Trial ID
NCT02138747
Treatments Being Tested
This is a 2-part study to assess if vibegron (MK-4618) reduces the number o...
Status
Completed
Location
Multiple Locations
Start Date
2011-03-31
Trial ID
NCT01314872
Treatments Being Tested